ClearBridge Investments
DYN icon

ClearBridge Investments’s Dyne Therapeutics DYN Stock Holding History

ClearBridge Investments’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.31M Sell
403,225
-4,569
-1% -$78.8K 0.01% 513
2025
Q4 		$7.98M Buy
+407,794
New +$7.72M 0.01% 526

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

ClearBridge Investments's DYN Position: Q1 2026 in Review

ClearBridge Investments reduced its Dyne Therapeutics (DYN) stake by 1.1% in Q1 2026, selling an estimated $78.8K and leaving 403,225 shares worth $7.31M. The position accounts for 0.01% of the portfolio, ranked #513.

ClearBridge Investments first reported a position in DYN in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.98M in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • ClearBridge Investments held 403,225 shares of Dyne Therapeutics worth $7.31M as of Q1 2026.
  • ClearBridge Investments sold 4,569 Dyne Therapeutics shares in Q1 2026, an estimated $78.8K.
  • Dyne Therapeutics made up 0.01% of ClearBridge Investments's portfolio in Q1 2026, its #513 holding.
  • ClearBridge Investments first reported a position in Dyne Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • ClearBridge Investments's Dyne Therapeutics position peaked at $7.98M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on ClearBridge Investments's 13F filing for Q1 2026, filed 13 May 2026.